loading page

Highlight the Effect of Pro-inflammatory Mediators in the pathogenesis of Periodontal Diseases and Alzheimer's Disease
  • +2
  • Nada Hashim,
  • Rasha Babiker ,
  • Muhammed Rahman ,
  • Riham Mohammed ,
  • Krishna Nallan
Nada Hashim
RAK Medical and Health Sciences University

Corresponding Author:[email protected]

Author Profile
Rasha Babiker
RAK Medical and Health Sciences University
Author Profile
Muhammed Rahman
RAK Medical and Health Sciences University
Author Profile
Riham Mohammed
RAK Medical and Health Sciences University
Author Profile
Krishna Nallan
RAK Medical and Health Sciences University
Author Profile

Abstract

Alzheimer’s disease (AD) is a neurological condition that is significantly more prevalent when people become older. It may start out early or late. A rise in levels of proinflammatory cytokines and microglial activation, both of which contribute to the central nervous system’s inflammatory state, are characteristics of AD (CNS). As opposed to this, periodontitis is a widespread oral infection brought on by gram-negative anaerobic bacteria. By releasing proinflammatory cytokines into the systemic circulation, periodontitis can be classified as a “low-grade systemic disease.” Periodontitis and AD are linked by inflammation, which is recognized to play a crucial influence in both the illness and treatment process. The current review sought to highlight the effects of pro-inflammatory cytokines, which are released during periodontal and Alzheimer’s diseases in the pathophysiology of both conditions. It also addresses the puzzling relationship between AD and periodontitis, highlighting the etiology, and potential ramifications.
22 Jul 2023Submitted to Immunity, Inflammation and Disease
26 Jul 2023Submission Checks Completed
26 Jul 2023Assigned to Editor
26 Jul 2023Review(s) Completed, Editorial Evaluation Pending
31 Jul 2023Reviewer(s) Assigned
19 Aug 2023Editorial Decision: Revise Major